Loading...

The Scientist

» literature, immunology and disease/medicine

Most Recent

A US judge issues a broad injunction that allows the society to demand that technology companies actively associated with the site block access to it.

3 Comments

image: Infographic: Breaking into the Brain

Infographic: Breaking into the Brain

By Amanda B. Keener | November 1, 2017

The blood-brain barrier is a collection of specialized cells and proteins that control the movement of molecules from the blood to the central nervous system.

2 Comments

image: The Wada Test, 1948

The Wada Test, 1948

By Philip Jaekl | November 1, 2017

A decades-old neurological procedure developed under unique and difficult conditions in postwar Japan remains critical to the treatment of epilepsy.

0 Comments

image: Getting Drugs Past the Blood-Brain Barrier

Getting Drugs Past the Blood-Brain Barrier

By Amanda B. Keener | November 1, 2017

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.

3 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: Opinion: Share Your Data

Opinion: Share Your Data

By Michael P. Milham, Arno Klein, and Cameron Craddock | October 24, 2017

Our analysis of a collection of open-access datasets quantifies their benefit to the scientific community.

2 Comments

image: Genetic Risk Factors for Breast Cancer Identified

Genetic Risk Factors for Breast Cancer Identified

By Ashley P. Taylor | October 23, 2017

Researchers identify 72 novel genetic variants associated with breast cancer risk.

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

These researchers join around 200 research institutions that have cut ties with the publishing giant to support the ongoing push for open access and favorable pricing.

1 Comment

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. The Second March for Science a Smaller Affair
  4. RNA Injection Restores Hearing in Guinea Pigs